ARCHIVE

• DIAGNOSTIC NEWS IN BRIEF
  June 3, 2002

• Tanabe's Mid-term Plan to Be Handed over to New President
  June 3, 2002

• MEDICAL DEVICE NEWS IN BRIEF
  June 3, 2002

• Sankyo, Sanwa Kagaku Tie Up on ARI, Ca Antagonist
  June 3, 2002

• Combined Sales of 27 JPMA Member Firms Up 4.9% to \5,526 Bil.
  June 3, 2002

• AstraZeneca, Shionogi to Comarket New Statin Crestor
  June 3, 2002

• Yamanouchi: Sales Up 5.1% Thanks to Harnal, Lipitor
  June 3, 2002

• Iressa to Be Approved in Japan before US, Europe
  June 3, 2002

• Eisai: Overseas Sales Up 53%, Accounting for 42.9% of Total Sales
  June 3, 2002

• Taiho Aims at Sales of \140 Bil. in 2004
  June 3, 2002

• Daiichi: Record-high Sales, Profits Thanks to Cravit
  June 3, 2002

• BUSINESS NEWS IN BRIEF
  June 3, 2002

• Taisho: Sales Down 1.1% due to Slump of OTC Drugs
  June 3, 2002

• NEW PRODUCTS
  June 3, 2002

• Banyu: Nu-lotan Contributes to Good Sales, Profits
  June 3, 2002

• 9 Drugs Including Elaspol to Be Included in NHI List
  June 3, 2002

• Sumitomo: Mainstays Drive Sales, Profits
  June 3, 2002

• Korosho Listens to Opinions from Industry on Its Proposed Industry Vision
  June 3, 2002

• Santen: Overseas Sales Make Up for Poor Domestic Performance
  June 3, 2002

• REGULATORY NEWS IN BRIEF
  June 3, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 676
• 677
• 678
• 679
• 680
• 681
• 682
• 683
• 684
• …
• Next ›
• 最終 »